Department of Pathology, University Hospital of Montpellier, Montpellier.
Department of Pathology, Centre Henri Becquerel, Rouen.
Am J Surg Pathol. 2024 Nov 1;48(11):1408-1416. doi: 10.1097/PAS.0000000000002281. Epub 2024 Aug 12.
DEK::AFF2 squamous cell carcinoma is a recently described cancer entity, with 29 cases reported to date. Occasionally, these carcinomas appear deceptively indistinguishable; however, specific morphological and phenotypic features suggest the presence of this rearrangement. However, the prognostic value of this diagnosis remains unclear. We aimed to report a new case series with histological, molecular, and clinical features.
We collected data from 15 patients and investigated their phenotypes, including the expression profiles of CK7, P63/P40, PDL1, AFF2, and P16, morphological features, and associated prognostic data. We analyzed these data along with the previously published data.
Most of these cases exhibited indicative morphological features, such as exophytic and endophytic papillary growth, nuclear monomorphism, and abundant neutrophil-rich inflammatory infiltrates. Immunohistochemical analysis revealed the expression of AFF2 and squamous cell markers in all the patients. Overexpression of P16 was not detected, whereas CK7 and PDL1 were expressed variably. In our study cohort, a 50% progression or recurrence rate, 25% lymph node metastasis, 17% distant metastasis, and 18% disease-related death were identified, with a short follow-up time.
DEK::AFF2 squamous cell carcinoma incidence is probably underestimated. The low-grade appearance of these tumors sometimes limits their detection. The rates of recurrence and metastasis seem to be high despite an often bland morphology. We propose AFF2 immunohistochemistry as an effective tool, and a diagnostic algorithm has been established to support accurate diagnosis of these tumors.
DEK::AFF2 鳞状细胞癌是一种最近描述的癌症实体,迄今为止已有 29 例报道。偶尔,这些癌似乎难以区分;然而,特定的形态和表型特征表明存在这种重排。然而,这种诊断的预后价值尚不清楚。我们旨在报告一系列具有组织学、分子和临床特征的新病例。
我们收集了 15 名患者的数据,并研究了他们的表型,包括 CK7、P63/P40、PDL1、AFF2 和 P16 的表达谱、形态特征和相关预后数据。我们分析了这些数据以及以前发表的数据。
这些病例中的大多数表现出提示性的形态特征,如外生性和内生性乳头状生长、核单形性和丰富的中性粒细胞丰富的炎症浸润。免疫组织化学分析显示所有患者均表达 AFF2 和鳞状细胞标志物。未检测到 P16 的过表达,而 CK7 和 PDL1 的表达则不同。在我们的研究队列中,50%的患者出现进展或复发,25%的患者出现淋巴结转移,17%的患者出现远处转移,18%的患者出现与疾病相关的死亡,随访时间较短。
DEK::AFF2 鳞状细胞癌的发病率可能被低估。这些肿瘤的低级别外观有时会限制其检测。尽管形态通常较温和,但复发和转移的发生率似乎较高。我们建议使用 AFF2 免疫组织化学作为一种有效的工具,并建立了一种诊断算法来支持这些肿瘤的准确诊断。